You are here:

Fentanyl transdermal (Durogesic®)


Recommended for restricted use within NHS Scotland.


Transdermal fentanyl should be considered as a second-line alternative for patients with intractable pain due to non malignant conditions. It should be reserved for patients whose pain has initially been controlled by oral means, the pain being relatively stable. Its use should focus on such patients who have difficulty swallowing or have problems with opiate induced constipation.

NB: Transdermal patches are significantly more expensive than oral therapy.

Drug Details

Drug Name: Fentanyl transdermal (Durogesic®)
SMC Drug ID: 24/02
Manufacturer: Janssen-Cilag Ltd
Indication: Chronic intractable pain
BNF Category:
Sub Category: 4.7 Analgesics
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 January 2003